Epigenomics AG Reports Second Quarter 2006 Financial Results

Epigenomics AG (Frankfurt, Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial results for the second quarter and first half ending June 30, 2006.

MORE ON THIS TOPIC